This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Xylem (XYL) Gains From End-Market Strength Despite Risks
by Zacks Equity Research
Xylem (XYL) gains from solid demand for products and services, a robust backlog level and the acquisition of Evoqua. However, rising operating costs and expenses might dent its margins.
Are Industrial Products Stocks Lagging Flowserve (FLS) This Year?
by Zacks Equity Research
Here is how Flowserve (FLS) and Mitsui & Co. (MITSY) have performed compared to their sector so far this year.
Flowserve (FLS) Q4 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Flowserve's (FLS) fourth-quarter revenues increase 12.1% driven by impressive performance of its Pump Division and Flow Control Division units.
Here's What Key Metrics Tell Us About Flowserve (FLS) Q4 Earnings
by Zacks Equity Research
The headline numbers for Flowserve (FLS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Flowserve (FLS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Flowserve (FLS) delivered earnings and revenue surprises of 11.48% and 2.56%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Barnes Group (B) Q4 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Barnes Group's (B) Q4 revenues increase 32.6% year over year, driven by the impressive performance of its Aerospace segment.
What's in the Offing for Flowserve (FLS) in Q4 Earnings?
by Zacks Equity Research
Flowserve's (FLS) fourth-quarter 2023 results are likely to benefit from strength in its Pump Division segment, driven by higher aftermarket and original equipment customer sales.
Ingersoll Rand (IR) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Ingersoll Rand's (IR) fourth-quarter 2023 results benefit from higher revenues of the Industrial Technologies segment.
What's in the Offing for Allegion (ALLE) This Earnings Season?
by Zacks Equity Research
Strength in the Allegion Americas segment and accretive acquisition are likely to aid Allegion's (ALLE) fourth-quarter 2023 results.
Honeywell (HON) Rides on Aerospace Business Strength Amid Risks
by Zacks Equity Research
Honeywell (HON) benefits from strength in its commercial aviation, defense and space businesses apart from acquired assets. However, softness in its warehouse and workflow solutions unit is concerning.
Nordson (NDSN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nordson (NDSN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Flowserve (FLS) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Flowserve (FLS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Here's Why You Should Hold Donaldson (DCI) in Your Portfolio
by Zacks Equity Research
Donaldson (DCI) benefits from strength in its industrial filtration solutions business, acquired businesses and shareholder-friendly policies. Softness in its Mobile Solutions unit is concerning.
MRC Global (MRC) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
MRC Global's (MRC) fourth-quarter revenues decrease 11.6% year over year due to lower volume in the Gas Utilities and PTI sectors.
Zacks.com featured highlights Amazon.com, e.l.f. Beauty, Wingstop, Flowserve and NVIDIA
by Zacks Equity Research
Amazon.com, e.l.f. Beauty, Wingstop, Flowserve and NVIDIA have been highlighted in this Screen of The Week article.
Flowserve (FLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Flowserve (FLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flowserve Corporation (FLS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Flowserve (FLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's What to Note Ahead of Ingersoll Rand's (IR) Q4 Earnings
by Zacks Equity Research
Ingersoll Rand's (IR) Q4 results are likely to benefit from solid demand, pricing actions and contributions from acquisitions. However, high operating expenses might have affected its margins.
Play Potential Earnings Beat With 5 Top-Ranked Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Amazon.com (AMZN), e.l.f. Beauty (ELF), Wingstop (WING), Flowserve (FLS) and NVIDIA (NVDA).
Is a Beat in Store for Atmus Filtration (ATMU) in Q4 Earnings?
by Zacks Equity Research
Atmus Filtration's (ATMU) fourth-quarter performance is expected to have gained from solid demand in first-fit markets. Growing popularity of its Fleetguard brand is likely to have aided results.
RBC Bearings (RBC) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
RBC Bearings' (RBC) third-quarter fiscal 2024 adjusted earnings increase 12.8% year over year, driven by higher revenues.
Enersys (ENS) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Enersys' (ENS) fiscal Q3 results benefit from the solid performance of the Specialty segment and lower cost of sales.
Berry Global (BERY) Q1 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Berry Global's (BERY) first-quarter fiscal 2024 revenues decline 7% year over year due to reduced demand in the consumer and industrial markets.
Zacks Industry Outlook Highlights Parker-Hannifin, IDEX, Applied Industrial, and Flowserve
by Zacks Equity Research
Parker-Hannifin, IDEX, Applied Industrial, and Flowserve have been highlighted in this Industry Outlook article.
IDEX (IEX) Q4 Earnings Surpass Estimates, Revenues Down Y/Y
by Zacks Equity Research
IDEX's (IEX) fourth-quarter 2023 revenues decrease 3% due to lower sales in the Health & Science Technologies segment.